Powered by

House panel says drugmakers inflated prices to boost profits and reap bonuses

Sep 30, 2020 - Politico

The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to show progress on slashing drug costs.

Major pharmaceutical companies raised drug prices exponentially by hundreds or thousands of percent to boost profits and executives' bonuses, "taking full advantage" of Medicare rules, a House panel said Wednesday.

The House Oversight and Reform Committee this morning reported the findings, the first from its 18-month investigation into a d...